Twist Bioscience Corp (TWST)
15.08
+0.34 (+2.34%)
USD |
NASDAQ |
Mar 31, 16:00
15.08
0.00 (0.00%)
Pre-Market: 20:00
Twist Bioscience Revenue (TTM): 215.79M for Dec. 31, 2022
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2022 | 215.79M |
September 30, 2022 | 203.56M |
June 30, 2022 | 184.21M |
March 31, 2022 | 163.11M |
December 31, 2021 | 146.19M |
September 30, 2021 | 132.33M |
June 30, 2021 | 126.82M |
March 31, 2021 | 113.00M |
December 31, 2020 | 101.10M |
September 30, 2020 | 90.10M |
Date | Value |
---|---|
June 30, 2020 | 73.40M |
March 31, 2020 | 65.80M |
December 31, 2019 | 60.06M |
September 30, 2019 | 54.39M |
June 30, 2019 | 47.06M |
March 31, 2019 | 40.00M |
December 31, 2018 | 32.61M |
September 30, 2018 | 25.43M |
June 30, 2018 | 20.49M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
20.49M
Minimum
Jun 2018
215.79M
Maximum
Dec 2022
99.76M
Average
90.10M
Median
Sep 2020
Revenue (TTM) Benchmarks
Perspective Therapeutics Inc | 8.967M |
Xtant Medical Holdings Inc | 57.97M |
Asensus Surgical Inc | 7.087M |
Ra Medical Systems Inc | -- |
Retractable Technologies Inc | 141.60M |